Skip to content

Perioperative Immunonutrition Intervention and Oral Decontamination in Elderly Surgical Patients

Effect of Perioperative Immunonutrition Intervention and Oral Decontamination on Postoperative Complications in Elderly: a Prospective Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05679661
Enrollment
590
Registered
2023-01-11
Start date
2023-02-06
Completion date
2026-01-01
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Complications

Brief summary

Elderly patients are vulnerable to postoperative complications. Preoperative malnutrition and poor oral hygiene are risk factors for postoperative complications especially pulmonary complications. This study aims to investigate the feasibility and efficacy of perioperative oral decontamination and immunonutrition supplement on reducing postoperative complications in elderly surgical patients.

Detailed description

This study is a prospective, single center, two-by-two factorial randomized controlled trial to evaluate the feasibility and efficacy of perioperative oral chlorhexidine decontamination and immunonutrition supplementation on postoperative complications in elderly surgical patients. Patients aged 65 years and older who are scheduled for elective non-cardiac surgeries will be recruited and randomized into four groups in 1:1:1:1 ratio (oral decontamination vs routine oral care with/without immunonutrition supplementation).

Interventions

DIETARY_SUPPLEMENTimmunonutrition

Patients in the intervention group will receive additional immunonutrition supplementation, which is oral intake of ORAL IMPACT™ 2 servings per day from the day of allocation at the preoperative anesthesia clinic until the day before surgery.

Patients in the intervention group will receive oral chlorhexidine decontamination using 0.12% chlorhexidine oral rinse twice daily from the day before surgery until postoperative day 3.

Sponsors

Huang YuGuang
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. age≥65 years; 2. undergoing non-cardiac surgery (expected duration \>2 hours); 3. scheduled for general anesthesia and endotracheal intubation; 4. ASA classification I-IV; 5. with intermediate to high risk of respiratory complications assessed by ARISCAT score (Assess Respiratory Risk in Surgical Patients in Catalonia); 6. inform consent obtained

Exclusion criteria

1. emergency surgery; 2. preoperative pneumonia; 3. allergic to chlorhexidine; 4. severe hepatic/renal dysfunction, incapable of oral feeding, with autoimmune diseases, taking immunosuppressant or immunoregulation medications, or with other contraindication to immunonutrition supplementation; 5. expected intervention of immunonutrition\<3 days.

Design outcomes

Primary

MeasureTime frameDescription
postoperative pulmonary complicationswithin 7 days after surgeryevaluated by trained investigator

Secondary

MeasureTime frameDescription
postoperative pneumoniawithin 7 days after surgerydefined according to the US Centers for Disease Control Definition
postoperative recoverywithin 30 days after surgeryevaluated by QoR-15 and WHODAS2.0
Comprehensive complication index (CCI)within 30 days after surgerypostoperative complication evaluated using Comprehensive complication index
Length of hospital stayFrom date of surgery until discharge day, assessed up to 4 weeksPostoperative length of hospital stay assessed by days

Countries

China

Contacts

Primary ContactLu Che, MD
tracymaobao@126.com69152020
Backup ContactJiawen Yu, MD
jiawen_yu@foxmail.com69152020

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026